Nouryon has joined forces with water treatment company Van Remmen UV Technology on a novel method to address the growing concern of pharmaceutical micropollutants in waste water. The process, which combines the Advanox™ ultraviolet (UV) treatment process from Van Remmen UV Technology and Nouryon’s MicrOx™ hydrogen peroxide, is expected to remove more than 90% of pharmaceutical residues.
“Growing global pharmaceutical use is creating a significant pollution problem for urban waste water treatment systems,” said Niek Stapel, Managing Director Pulp and Performance Chemicals at Nouryon. “With this advanced water treatment concept, customers in the water treatment market will have access to two proven technologies that together enable measurement, monitoring and means to control micropollutants in waste water streams.”
The process is being tested in a plant that treats the sewage of the city of Växjö, Sweden.
Ton van Remmen, CEO at Van Remmen UV Technology, added: “Each partner is an expert in a different aspect of water treatment – Van Remmen in UV disinfection and advanced oxidation and Nouryon in peroxide application. By combining our respective knowhow, we can offer the improved oxidation solution the world needs to address this growing problem.”
Related content
About Nouryon
Nouryon is a global, specialty chemicals leader. Markets and consumers worldwide rely on our essential solutions to manufacture everyday products, such as personal care, cleaning goods, paints and coatings, agriculture and food, pharmaceuticals, and building products. Furthermore, the dedication of approximately 8,200 employees with a shared commitment to our customers, business growth, safety, sustainability and innovation has resulted in a consistently strong financial performance. We operate in over 80 countries around the world with a portfolio of industry-leading brands.